Extended Reality-Assisted Therapy for Chronic Pain Management
NCT ID: NCT06296433
Last Updated: 2024-05-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
100 participants
INTERVENTIONAL
2024-04-01
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Is a prototype of a novel VR software application effective at reducing pain, improving daily function, improving range of motion, and reducing fear of movement in adult patients with chronic low back pain compared with a passive VR intervention? Participants in the treatment group will use the application daily for 20 minutes for a period of 3 weeks at home and unsupervised. Researchers will compare use of the VR application with a control group that watches 2D video to see if the treatment group have improved pain, disability, range of motion, and fear of movement.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Virtual Reality Therapy for Chronic Low Back Pain
NCT04409353
Virtual Reality Treatment for Adults With Chronic Back Pain
NCT04468074
Virtual Reality Trial Using EaseVRx For Chronic Low Back Pain
NCT04415177
Feasibility Study on an Immersive Virtual Reality Tool in the Treatment of Chronic Low Back Pain
NCT04781465
Analgesic Effect of a Prototype Device of Virtual Reality in a Population of Patients With Chronic Low Back Pain
NCT01407653
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Patients in the VR intervention group will use the VR software application daily for a 20-minute training program. In the virtual reality application, they will be embodied into an avatar through congruent visuotactile and visuomotor stimulation (observed in first person) and will perform gamified movements and exercises for 15-20 minutes. These exercises will increase in difficulty for 3 weeks and will include educational and relaxation components. The control treatment will consist of a passive VR intervention in which the patient watches a TV show on a 2D screen but while wearing the virtual reality headset. They will be able to choose from three popular TV series with short episodes (20 minutes). The investigators will use validated outcome measures to assess changes in pain and function. These will be measured at baseline, after treatment (3 weeks), and at 1 month follow-up for both the treatment group and the control group. Both groups will be advised to continue their normal daily activities and routines, with no restrictions on activity or exercise, in addition to VR treatment.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
VR rehabilitation treatment
Daily use of VR rehabilitation program independently at home for a period of 3 weeks. Each daily session is 20 minutes.
VR rehabilitation
VR software application containing education, exergames, therapeutic exercises and relaxation sections.
VR control treatment
Daily watching 2D video independently at home using VR headset for a period of 20 minutes.
VR video application
VR software application that plays 2D nature videos
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
VR rehabilitation
VR software application containing education, exergames, therapeutic exercises and relaxation sections.
VR video application
VR software application that plays 2D nature videos
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of chronic low back pain of \>12 weeks, with or without associated somatic referred leg pain
* Average pain intensity over the previous month ≤7/10 and ≥ 2/10)
Exclusion Criteria
* Acute radiculopathy or compromised nerve root
* Recent spinal surgery (\<12 months) or lower limb surgery (\<3 months)
* Major depressive symptoms as indicated by the Patient Health Questionnaire-2 depression screen score of 4 or more.
* Current or prior diagnosis of epilepsy, seizure disorder, dementia, migraines, balance disorder, or other neurological diseases that may prevent the use of virtual reality or adverse effects.
* Cardiopulmonary or pulmonary disorder with contraindication to physical exercise
* Pregnancy
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Institut d'Investigacions Biomèdiques August Pi i Sunyer
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Prof. Maria V. Sanchez-Vives
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Maria V Sanchez-Vives
Role: PRINCIPAL_INVESTIGATOR
Institut d'Investigacions Biomèdiques August Pi i Sunyer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
IDIBAPS
Barcelona, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HCB_2023_1196
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.